Sloan Kettering Executive Turns Over Windfall Stake in Biotech Start-Up

Sloan Kettering Executive Turns Over Windfall Stake in Biotech Start-Up

September 30, 2018
With the cancer center’s corporate ties under scrutiny, the hospital told employees that no one should profit personally from representing MSK on outside boards.

from NYT > Home Page https://ift.tt/2IpPvlz
Unknown

Share this

Related Posts

Next
« Prev Post
Previous
Next Post »
Subscribe to: Post Comments (Atom)